Koyfin Home > Directory > Health Care > Aduro Biotech > EV / EBITDA (ltm)

Aduro Biotech EV / EBITDA (ltm) Chart (ADRO)

Aduro Biotech annual/quarterly EV / EBITDA (ltm) from 2018 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Aduro Biotech EV / EBITDA (ltm) for the quarter ending March 03, 2020 was 0.00 a -53,510.66% decrease of -0.58 year over year
  • Aduro Biotech EV / EBITDA (ltm) for the last 12 months ending March 03, 2020 was 0.00 a -53,510.66% decrease of -0.58 year over year
  • Aduro Biotech Annual EV / EBITDA (ltm) for 2020 was 0.00 a -21,869.95% decrease of -0.24 from 2019
  • Aduro Biotech Annual EV / EBITDA (ltm) for 2020 was 0.24 a 10.84% increase of 0.03 from 2019
  • Aduro Biotech Annual EV / EBITDA (ltm) for 2020 was 0.21 a -173.69% decrease of -0.37 from 2019
Other Valuation Metrics:
  • Aduro Biotech Market Cap for the quarter ending March 03, 2018 was $753m a -5.79% decrease of -44m year over year
  • Aduro Biotech Price / Book for the quarter ending March 03, 2018 was 3.04 a -14.05% decrease of -0.43 year over year
  • Aduro Biotech Enterprise Value for the quarter ending March 03, 2018 was $427m a -3.70% decrease of -16m year over year
View Chart On Koyfin

Quarterly ADRO EV / EBITDA (ltm) Data

03/20200.00
03/20200.24
02/20200.21
02/20200.58
01/20200.76
01/20201.08
01/20201.03
01/20200.96
01/20201.03
01/20200.96

Annual ADRO EV / EBITDA (ltm) Data

20200.00
20200.24
20200.21
20200.58
20200.76
20201.08
20201.03
20200.96
20201.03
20200.96